WHO Approves Second Mpox Vaccine For Emergency Use
The World Health Organization (WHO) has approved a second mpox vaccine for emergency use. This vaccine, known as LC16m8, is developed by the Japanese pharmaceutical company KM Biologics. The approval aims to make vaccines more accessible to communities experiencing a surge in mpox outbreaks. Here’s everything you need to know about this significant step in […]







